dx.doi.org/10.1097/hs9.0000000000000325, hdl.handle.net/1765/128616
Department of Hematology

Stevens, WBC, Bakunina, K., Cuijpers, M., Chamuleau, M., Beeker, A, Fijnheer, R, … Kersten, M.J. (2020). HOVON110/ReBeL Study: Results of the Phase I Part of a Randomized Phase I/II Study of Lenalidomide, Rituximab With or Without Bendamustine in Patients With Relapsed/Refractory Follicular Lymphoma. HemaSphere, 4(1). doi:10.1097/hs9.0000000000000325